Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using
Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is headquartered in La Jolla, California. The company trades on NCM exchange. The company headquarter is located in La Jolla, United States.
| Ticker | ENSC |
| Long Name | Ensysce Biosciences, Inc. |
| Short Name | Ensysce Biosciences, Inc. |